Validation pour Ingenuity254

vers la météo de la validation par utilisateur

Ingenuity254

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 49 - PMID ?

In liver from adult SP , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of SP NODE protein .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 1

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 2

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 3

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 4

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 5

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 6

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 7

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                                     +COMP:N-N(o+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+               +MOD_ATT:+      +MOD+         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |               |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 8

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 9

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 10

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 11

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 13

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                                   +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      +--COMP:N-N(from)-+                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 14

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 15

      +-----------------------------------------COMP:V-N(In)-----------------------------------------+                                          
      |                 +-------------------------------COMP:V-N(from)-------------------------------+                                          
      |                 |                 +-------------------------SUBJ:V-N-------------------------+         +-------COMP:N-N(of)-------+     
      |                 |                 |                   +-----------OBJ:V-N----------+         |         |          +-MOD_ATT:N-ADJ-+     
      |          +MOD_AT+       +MOD_ATT:N+COMP:N-N(of)+      |        +MOD_ATT:+COMP:N+   |         +-OBJ:V-N-+          |       +MOD_ATT+     
      |          |      |       |         |            |      |        |        |      |   |         |         |          |       |       |     
 In liver from adult __SP__ , oral administration of CFAM ( with a treatment period of 2 weeks ) increases activity of __SP__ __NODE__ protein .
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,CFAM)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,activity)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)